Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,516.00
Bid: 12,554.00
Ask: 12,556.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.016%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,516.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks finish lower as ECB stands pat

Thu, 11th Apr 2024 15:56

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

The FTSE 100 closed down 0.47% at 7,923.80 points, while the FTSE 250 experienced a marginal decline of 0.08%, closing at 19,786.87 points.

In currency markets, sterling was last down 0.06% on the dollar, trading at $1.2532, while it strengthened 0.18% against the euro to change hands at €1.1693.

"The FTSE 100 saw a slight increase [earlier] as investors shifted their attention from the higher-than-expected US inflation data to the European Central Bank's interest rate decision," said TickMill market analyst Patrick Munnelly.

"The internationally-focused index saw a slight decline post the ECB announcement, where it held the bank rate at 4%.

"ECB president Christine Lagarde did not commit to a specific policy path."

Munnelly said the ECB's statement indicated that if inflation and monetary policy transmission increased confidence in returning price growth to target, it would be appropriate to reduce monetary policy restrictions.

"Investors inferred that means a rate cut in June is likely.

"However, president Lagarde's comments during the post-meeting press conference left traders uncertain about the future development of policy after June."

Wholesale prices rise modestly in the US, ECB stands pat on rates

In economic news, US wholesale prices saw a modest increase last month, falling slightly short of expectations.

The Department of Labor reported a 0.2% month-on-month rise in seasonally adjusted total final demand prices in March, with food prices climbing by 0.8%.

However, energy prices experienced a 1.6% decline, serving as a partial offset.

On a year-on-year basis, producer prices were up by 2.1%, indicating a steady yet moderate pace of inflation.

"After another sizzling CPI report, producer prices offer some relief for Fed officials who may view the recent price reports as too hot to consider rate cuts in the immediate future," said Matthew Martin, US economist at Oxford Economics.

"While we see the odds of the first rate cut occurring in September rising, cooler reports such as the PPI report keep the June meeting on the table, which is our current baseline."

Meanwhile, initial jobless claims in the US dropped to 211,000 in the week ended 6 April, marking the lowest reading in a month and undershooting market expectations, while continuing claims also decreased.

Closer to home, the European Central Bank (ECB) opted to maintain its current interest rates, signalling a cautious approach amid uncertainties surrounding inflation and geopolitical events.

ECB president Christine Lagarde emphasised the potential impact of geopolitical tensions on economic growth and prices, acknowledging the importance of energy price fluctuations in shaping inflation dynamics.

The ECB's stance remained contingent on future economic projections, with a willingness to adjust interest rates if needed to support price stability.

On home shores, the UK housing market showed signs of resilience, with buyer demand strengthening and house price trends improving.

According to the RICS UK residential survey, buyer demand reached its most positive level since February 2022 in March, while new instructions also increased.

House price trends continued to improve for the seventh consecutive month, indicating a stabilising market despite ongoing uncertainties.

"Demand continues to recover gradually across the UK housing market, with new buyer enquiries rising for a third month in succession," said Tarrant Parsons, senior economist at the Royal Institution of Chartered Surveyors.

"With the inflation backdrop turning a little less difficult of late, this has led to expectations that the Bank of England will be able to start lowering interest rates later in the year.

"This should continue to support the market to a certain degree going forward."

Ex-divs prove a big drag, Kingfisher rises on upgrade

On London's equity markets, ex-dividend stocks proved a major drag, with Aviva, Barratt Developments, Lloyds, Reckitt Benckiser, Phoenix Group, Smurfit Kappa, Man Group, Howden Joinery, Just Group, Savills, TP ICAP, Harbour Energy, Hunting and ITV all in the red as a result.

Travel shares were under pressure amid concerns over potential geopolitical tensions, with IAG, easyJet, Carnival, and Wizz Air Holdings all registering losses.

Jupiter Fund Management faced downward pressure following a downgrade from Barclays.

On the upside, B&Q and Castorama owner Kingfisher rose 2.44% after receiving an upgrade to 'buy' from HSBC.

AstraZeneca increased 2.14% after announcing a 7% rise in its annual dividend, while Great Portland Estates added 1.61% on the back of strong demand and expectations of a rate cut.

Cybersecurity specialist Darktrace jumped 5.82% after raising its guidance for the year following robust third-quarter results.

Elsewhere, Marks & Spencer received a boost after an upgrade from JPMorgan, while outside the FTSE 250, Lok'n Store Group rocketed 16.91% following an acquisition agreement with Belgian rival Shurgard.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,923.80 -0.47%

FTSE 250 (MCX) 19,786.87 -0.08%

techMARK (TASX) 4,458.35 0.37%

FTSE 100 - Risers

Centrica (CNA) 130.30p 3.41%

Smiths Group (SMIN) 1,647.00p 2.68%

Kingfisher (KGF) 248.00p 2.44%

AstraZeneca (AZN) 10,962.00p 2.14%

Rightmove (RMV) 535.80p 1.90%

Unite Group (UTG) 937.50p 1.68%

Hikma Pharmaceuticals (HIK) 1,817.00p 1.62%

Imperial Brands (IMB) 1,701.50p 1.58%

SSE (SSE) 1,605.50p 1.32%

Intermediate Capital Group (ICP) 2,114.00p 1.25%

FTSE 100 - Fallers

Aviva (AV.) 458.80p -6.35%

Phoenix Group Holdings (PHNX) 511.00p -5.81%

Tesco (TSCO) 282.00p -5.05%

Lloyds Banking Group (LLOY) 50.66p -4.63%

International Consolidated Airlines Group SA (CDI) (IAG) 169.10p -3.67%

easyJet (EZJ) 547.20p -3.61%

Barclays (BARC) 183.64p -3.08%

Sainsbury (J) (SBRY) 259.80p -2.77%

HSBC Holdings (HSBA) 646.70p -2.49%

Reckitt Benckiser Group (RKT) 4,206.00p -2.30%

FTSE 250 - Risers

Darktrace (DARK) 466.20p 6.25%

Watches of Switzerland Group (WOSG) 373.00p 5.13%

Safestore Holdings (SAFE) 760.50p 4.54%

Drax Group (DRX) 497.20p 2.90%

Close Brothers Group (CBG) 483.40p 2.68%

Bytes Technology Group (BYIT) 510.00p 2.57%

Big Yellow Group (BYG) 1,044.00p 2.55%

Diversified Energy Company (DEC) 1,106.00p 2.50%

Centamin (DI) (CEY) 127.90p 2.32%

Workspace Group (WKP) 509.00p 2.22%

FTSE 250 - Fallers

TUI AG Reg Shs (DI) (TUI) 646.00p -4.58%

Man Group (EMG) 264.60p -3.85%

TP Icap Group (TCAP) 214.00p -3.83%

Savills (SVS) 1,020.00p -3.77%

W.A.G Payment Solutions (WPS) 68.80p -3.46%

ITV (ITV) 70.70p -3.42%

Wizz Air Holdings (WIZZ) 2,280.00p -3.14%

Jupiter Fund Management (JUP) 87.70p -3.09%

Carnival (CCL) 1,062.50p -2.88%

Aston Martin Lagonda Global Holdings (AML) 159.80p -2.80%

More News
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more
3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the European Union.

Read more
3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.

Read more
2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worsened after endocrine therapy - even if they had very low levels of the mutant protein targeted by the drug, according to trial results announced on Sunday.

Read more
2 Jun 2024 15:58

Astra's Enhertu delays breast cancer in patients with low HER2 levels

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu was shown in a large trial to delay the growth of hormone-sensitive breast cancer by about five months for people with low levels of HER2 protein whose cancer progressed following endocrine therapy, according to research presented on Sunday.

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an oral small molecule PCSK9 inhibitor. Administered on top of rosuvastatin treatment, AZD0780 showed a statistically significant reduction in low-density lipoprotein cholesterol in plasma for test participants with hypercholesterolaemia, Astra says, while no serious adverse events were reported. "Elevated LDL-C levels in plasma is a key risk factor for cardiovascular disease and is estimated to cause 2.6 million deaths worldwide annually," Astra notes.

Read more
28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.